Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
BIOTRICITY INC. incurred convertible notes of $1,000,000 at 12% per annum maturing the earlier of 18 months or the 18 month anniversary of the last closing date.
- Instrument
- convertible notes
- Principal
- $1,000,000
- Rate
- 12% per annum
- Maturity
- the earlier of 18 months or the 18 month anniversary of the last closing date
- Event
- incurrence
Exact text from the filing
On October 31, 2023, Biotricity Inc. (the “Company”) entered into a subscription agreement (the “Agreement”) pursuant to which the Company issued an unsecured convertible preferred note (the “Note”) in the principal amount of $1,000,000 to an investor (“Investor”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
BIOTRICITY INC. entered into Agreement valued at $1,000,000 (effective 2023-10-31).
- Action
- entry
- Agreement
- notes offering
- Value
- $1,000,000
- Effective
- 2023-10-31
Exact text from the filing
On October 31, 2023, Biotricity Inc. (the “Company”) entered into a subscription agreement (the “Agreement”) pursuant to which the Company issued an unsecured convertible preferred note (the “Note”) in the principal amount of $1,000,000 to an investor (“Investor”).
View on SEC.gov